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Abstract: The lack of adequate blood/lymphatic vessels as well as low-potential articular cartilage
regeneration underlines the necessity to search for alternative biomaterials. Owing to their unique
features, such as reversible thermogelling behavior and tissue-like mechanical behavior, agarose-based
biomaterials have played a key role in cartilage tissue repair. Accordingly, the need for fabricating
novel highly efficient injectable agarose-based biomaterials as hydrogels for restoration of injured
cartilage tissue has been recognized. In this review, the resources and conspicuous properties
of the agarose-based biomaterials were reviewed. First, different types of signals together with
their functionalities in the maintenance of cartilage homeostasis were explained. Then, various
cellular signaling pathways and their significant role in cartilage tissue engineering were overviewed.
Next, the molecular structure and its gelling behavior have been discussed. Eventually, the latest
advancements, the lingering challenges, and future ahead of agarose derivatives from the cartilage
regeneration perspective have been discussed.
Keywords: agarose; biomaterials; hydrogels; cartilage; tissue engineering; regenerative medicine
1. Introduction
Millions of people in the world are suffering from articular cartilage diseases (ACD) and its side
effects, such as anterior cruciate ligament (ACL) and osteochondral defects (OCD). It is expected that
OCD will be the principal reason for incapacity in the next decades, with 35% of the population affected.
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The occurrence of OCD depends on age, gender, and environmental conditions. Although treating the
defects using surgeries is promising, cartilage regeneration remains as a post-surgery complication
because of its structural complexity and low metabolic performance [1,2]. Furthermore, the long-term
healing period of internal articular cartilage demands new strategies for repairing cartilage without
surgery [3].
Tissue engineering is an interdisciplinary branch of science for designing and implementing novel
treatment strategies based on natural/synthetic materials along with cell and therapeutic agents to treat
the injured tissues [4–6]. Tissue engineering has opened a promising path to regenerate the cartilage
using modified natural/synthetic biomacromolecules. The first step in material selection for tissue
engineering is the tissue recapitulation by the selected scaffold [7–9]. Therefore, the mechanical behavior
of the intended material should match with its nearby cartilage in order to keep its function [10,11].
Biopolymers such as chitosan [12,13], alginate [14,15], gelatin [16,17], and agarose [18] have been widely
used for tissue engineering [19,20] because of their proper biocompatibility, controllable degradability,
and tissue-mimicking performance.
Agarose has been used vastly in biomedical applications because of its controlled self-gelling
properties, water-solubility, adjustable mechanical properties, and non-immunogenic properties.
Agarose, based on its stiffness and functional groups, can support cellular adhesion, proliferation,
and activity. Agarose has adjustable water adsorption capacity, which provides the cells with a
suitable microenvironment for cellular activity [21]. Agarose-based hydrogels have considerably been
utilized in the investigation of mechanical load reaction for chondrocytes and mesenchymal stem cells
(MSCs) [22]. Agarose has acquired a wide range of applications such as drug delivery [23,24], cancer
therapy [25,26], tissue engineering and regenerative medicine [27–30], and disease diagnosis, controlling,
and treatment [31–33]. It has been utilized in various tissue engineering applications, including the
neural system [34], bone formation [35], cardiac regeneration, wound healing, and attachment to
tissues such as skin [36], brain [37], and cornea. The properties of agarose are tunable by concentration,
functionalization, and blending to mimic the desired tissue performance. Figure 1 exhibits the agarose
gel performance for various tissues and cells.
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Figure 1. Adjustable features of agarose can result in flexible characteristics similar to cells and tissues.
Here, the conductivity and Young’s modulus of agarose-based biomaterials are patterned. Reprinted
with permission from [18].
2. Cartilage Types, Properties, and Formation
Cartilage is a smooth elastic tissue, which covers the end of bones at the joints and protects
them against mechanical stresses. There are three types of cartilage: articular (hyaline), fibrous,
and elastic [38,39]. Heterotypic collagen II/IX/XI fibrils and proteoglycan–glycosaminoglycan networks
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of aggrecan and hyaluronan are the dominant structures of the cartilage extracellular matrix (ECM).
Hyaline is an elastic, flexible, and wear-resistant tissue that is accessible inside the joint to carry and
disrupt the weight. The cartilages of the ear, larynx, and epiglottis are more elastic than the hyaline.
Fibrocartilage as inexorable cartilage is available in the knee and between the vertebrae [40].
Low-speed regeneration of cartilage tissue is chiefly because of a lack of blood vessels and nerves.
This phenomenon may lead to rheumatoid arthritis, inflammatory disease, and deterioration of the
joints, causing pain for a long time. Collagen (type II), hyaluronan, and dormant sulfate are the major
components of the cartilage tissue ECM. Cartilage damage is accompanied by ECM degradation and
mobilization of joint chondrocytes from other areas with decreased infiltration and vascularization of
inflammatory cells. Figure 2 shows the cartilage structure [41].
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Figure 2. Schematic of the cartilage tissue struct e. (a) Collagen (type II) and chondrocytes are two
major components of cartilage tissue, the application of cartilage tissue in different parts of the human
body (reproduced with permission from [42]).
Different biomaterials c e utilized in repairi g the cartil ge; however, we should point out that
the signal paths and biological signs involved in the cartilage are activated so that we can begin to
interact and reconstruct the muscles. Chondrogenesis is a process by which various cellular signals
are sent in the egulation of cartilage f rmatio [43]. Multipl factors have b en announced for
cartilage repair, such as transforming growth factor β (TGFβ), parathyroid hormone-related protein
(PTHrP), Wnts, Indian hedgehog, thyroid hormone, bone morphogenetic protein (BMP) superfamily,
platelet-derived fact rs (PDGFs), i sulin-like growth factor (IGFs), fibroblast growth factors (FGFs),
and different vitamins (Table 1) [44]. TGFβs play a vital role in regulating the proliferation/differentiation
of chondrocytes. TGFβ stimulates the RY-box expression causing the formation of collagen type II
and aggrecan in the early condensation phase of MSCs [45]. Wnt and β-catenin-dependent signaling
pathways possess vital functions in developing chondrocytes (Table 2). The β-catenin-dependent
stimulates endochondral ossification and axial growth [44].
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Table 1. The different types of signal plus their functionalities and crucial roles in the maintenance of
cartilage homeostasis [43].
Type of Signal Role (Duty)
TGF-β Regulates the proliferation/differentiation of chondrocytes, and stimulates theRY-box expression
BMP
Plays an important role in various stages of skeletal growth, and the commitment of
mesenchymal cells to the lines of chondrocytes in the induction of proliferation and cell
maturation in the growth and formation of the joints and bones
IGF Develops cartilage and reproduces chondrocytes on the growth plate
FGF Develops vital organs
Table 2. Various cellular signaling pathways and their significant role in cartilage tissue engineering.
Signaling Pathway Role (Duty)
SMAD Expresses pre-hypertrophic and proliferative and hypertrophic chondrocytesin all regions of the cartilage
b-catenin-dependent Stimulates bone growth in axial growth, and induces endochondralossification and axial growth
Non-canonical WNT Creates growth pillars by chondrocytes
3. Agarose Properties
Extraction of agar from the algae source [46], Ahnfeltia plicata [47], Gelidium amansii [48],
and Eucheuma [49], using chemical treatment (NaOH [50], ionic liquids [51], Na2CO3 [50]), is the main
method conducted, as illustrated by the steps detailed in Figure 3. Agar was utilized as a source of
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sulfoxide (DMSO), dimethylformamide (DMF), formamide (FA), N-methylformamide (MFA), and 1-
Butyl-3-methylimidazolium chloride (BmimCl) [52,53]. Agarose is a part of the agar that is obtained 
by separating the agar–peptide. Various factors such as molecular weight, concentration, and lateral 
groups significantly affect the melting and gelling temperature [19,52,54]. Overall, 1.5% of each 
agarose type, such as types II, VII, and IX-A, have different gelling and melting temperatures, at 26, 
26–30, and 17 °C, respectively [55]. 
The agarose gelation process is divided into three stages: induction, gelation, and quasi-
equilibrium [56,57]. The mechanism of gelation is usually characterized using rheological 
experiments [56], and it includes nucleation and growth of nuclei. Several agarose nuclei are formed 
in the first step followed by the growing of nuclei, which gradually form agarose-rich networks 
(Figure 4). In agarose, the formation of gel is related to the agarose molecule twisting linked to the 
transplantation of hydrogen and electrostatic penetration [58]. In the end, it is essential to note that 
the concentration of the agarose gel determines its permeability [59]. 
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The molecular weight of agarose is almost 120,000 g/mol (12 kDa). It is in the form of a
white powder that dissolves in hot water to form a gel when cooled to below an upper critical
solution temperature (UCST) [18]. Furthermore, agarose dissolves in several organic solvents such
as dimethyl sulfoxide (DMSO), dimethylformamide (DMF), formamide (FA), N-methylformamide
(MFA), and 1-Butyl-3-methylimidazolium chloride (BmimCl) [52,53]. Agarose is a part of the agar that
is obtained by separating the agar–peptide. Various factors such as molecular weight, concentration,
and lateral groups significantly affect the melting and gelling temperature [19,52,54]. Overall, 1.5% of
each agarose type, such as types II, VII, and IX-A, have different gelling and melting temperatures,
at 26, 26–30, and 17 ◦C, respectively [55].
The agarose gelation process is divided into three stages: induction, gelation,
and quasi-equilibrium [56,57]. The mechanism of gelation is usually characterized using rheological
experiments [56], and it includes nucleation and growth of nuclei. Several agarose nuclei are formed in
the first step followed by the growing of nuclei, which gradually form agarose-rich networks (Figure 4).
In agarose, the formation of gel is related to the agarose molecule twisting linked to the transplantation
of hydrogen and electrostatic penetration [58]. In the end, it is essential to note that the concentration
of the agarose gel determines its permeability [59].
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A big challenge in cartilage tissue engineering is to achieve mechanical properties similar to
cartilage itself [60]. Agarose hydrogels can be an appropriate selection for cartilage tissue engineering
because of the adjustable mechanical properties, swelling ratio, and therapeutic fac ors. The mechanical
properties of agarose can be tuned by altering the concentration. For instance, the elastic modulus for
different concentrations of agarose with compression membranes has been calculated from 0.5%, 1.0%,
2.5%, and 5.0% of the agarose gel as 5.3, 38, 254, 929 KPa, respectively [61].
Comparing Young’s modulus of different body organs with agarose is of particular interest
in tissue engineering (Figure 1), but on the other hand, Young’s modulus of agarose is less than
0.5 MPa [62,63], indicating that garose has high-pressure tolerance compared to natural tissues.
Young’s moduli for bone, cartilage, nerve, cardiac, skeletal muscle, endothelium, liver, and lung
are in the range of 1–20 GPa [64], 10–20 KPa [65], 0.1–2 KPa [66], 30–400 KPa [67], 20–100 KPa [68],
1–7 KPa [69], 0.3–0.8 KPa [70], and 1–5 KP , respectively [70].
The mechanical behavior of agarose is comparable to articular cartilage upon static or dynamic
loading [71,72]. Since cartilage and agarose are both hydrated materials, they exhibit strain-dependent
hydraulic permeability, which means that resistance to water transportation through the hydrogel
increases with the increase of applied deformation (and the collapse of the p res) [73].
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4. Agarose in Cartilage Regeneration
Cartilage exhibits arduous regeneration because of its avascular nature. Therefore, cartilogenesis
is known as a challenging field in regenerative medicine and tissue engineering. Cartilage as
a microenvironment possesses a hypoxic condition that facilitates the differentiation of MSCs to
chondrogenesis rather than osteogenesis [74]. The degree of success in cartilage tissue engineering is
pertinent to the cells, growth factors, and biomaterials. Moreover, the age and size of the injured section
impacts the regeneration process. Biomaterials in cartilage repair, along with proper biocompatibility
and biodegradability, should offer a suitable milieu for proliferation, differentiation, and migration of
chondrocytes. Guaccio et al. revealed that cartilage growth is usually diminished by the problem of
inadequate oxygen/nutrient source to cultured cells in 3D platforms. It was understood that oxygen
utilization level is two times greater in agarose compared to collagen, indicating that the nature of the
material greatly impacts cell metabolic performance [75]. Applying an agarose hydrogel-based scaffold
for cartilage regeneration stabilized the chondrocyte phenotype and enhanced the proteoglycan and
glycosaminoglycans precipitation [76]. Cigan et al. encapsulated the human chondrocyte in an agarose
scaffold for cartilage regeneration. Engineered cartilaginous structure substantially appeared like
native human cartilage, and possessed compressive Young’s and dynamic moduli of about 250 and
950 kPa, respectively. Moreover, it was composed of 5.7% (w/w) of glycosaminoglycans and 1.5% (w/w)
collagen [76]. Implantation of autologous chondrocyte is a recognized technique for symptomatic
articular flaws. Selmi et al. used agarose-based hydrogel to enhance cell phenotypic constancy and
improve surgical management. Overall, seventeen patients were used as clinical trials and were
surveyed for two years. Clinically, all the patients were treated substantially. Patients with defects
more than 3 cm2 were improved drastically compared to those with smaller ones. Moreover, in eight
cases, dominant hyaline cartilage-like repair tissue was detected [77]. Kock et al. studied the agarose
concentration on chondrocyte behavior [19]. Matrix formation around the chondrocyte was affected
by agarose concentration. A low concentration of agarose facilitated the proteoglycans diffusion.
Agarose with 1% concentration resulted in collagen II deposition in a radial manner, while 2% and
3% agarose concentrations resulted in a dense layer of collagen formation around the cell. The 1%
agarose contained more proteoglycans compared to those having 2% and 3% agarose. It was deduced
that the agarose concentration reduction caused more nutrient diffusion and enhancement of matrix
deposition like collagen fibril. At lower concentrations of agarose, a uniform matrix was developed
that increased the modulus at equilibrium state. Therefore, low concentration agarose increased the
deposition of the extracellular matrix, which improved the mechanical properties [60]. In Table 3,
the mechanical properties, the concentrations and the methods of applications of agarose-based
biomaterials are presented.
Polymers 2020, 12, 1150 7 of 15
Table 3. A brief view at the mechanical properties, concentrations, and the methods of applications of agarose-based biomaterials in biomedical applications.
Material Concentration % MechanicalProperties (KPa) Methods Action Ref.
Agarose 1 10
The effect of TGF-b3 was compared to the
fatal bovine serum. Mechanical properties
were assessed at day 42.
Low-concentration agarose stimulates the
formation of more Homogeneous
ECM distribution.
The presence of TGF-b3 is also beneficial
because it stimulates the distribution of
matrix components.














Agarose-TGF 1 disc 38
Agarose 2 1.547
Gel
Both the volume fraction of water and
hydraulic permeability decreased with
increasing agarose gel concentration.









PRP-agarose 7 days14 days
32
50 Porcine chondrocytes were seeded in agarose
gel and platelet-rich plasma–agarose gel.
The hydrogel possesses a proper
microenvironment for chondrocyte growth,
proliferation and matrix formation
[79]
28 days 75
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Table 3. Cont.
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Agarose blending enhances its cellular activity and regeneration. Singah et al. blended the agarose
with silk to regenerate the cartilage [53]. The results indicated that the silk/agarose scaffold increased
sulfated glycosaminoglycans (sGAG) and collagen deposition as a signature of the preservation of
chondrogenic phenotype. Moreover, it was revealed that up-regulation of cartilage-specific aggrecan,
sox-9 (∼1.5-fold) and collagen type II (∼2-fold) marker genes (p ≤ 0.01) in blended hydrogels collagen
and fibronectin colocalization was a suitable method to improve the agarose microenvironment for
chondrocytes culture. Furthermore, the connection between collagen or fibronectin with chondrocytes
and the connection between chondrocytes with living cartilage resulted in an increasing matrix and
cohesion of matrix–matrix that improved cartilage regeneration [70]. Platelet-rich plasma (PRP) is
the source of known growth factors. Thus, a scaffold was made using a platelet-rich plasma–agarose
gel, and the results showed that PRP–agarose gel was extensively uniform in the structure with
high-level concentration, as a signal of an increased amount of collagen type -I mRNA expression
in the structure [79]. Dekosky et al. synthesized an interpenetrating network of hydrogels based
on agarose/Poly(ethylene Glycol) to encapsulate cells for cartilage regeneration [81]. Espinosa et al.
synthesized a magnetic fibrin–agarose hydrogel for cartilage regeneration. It was noticed that magnetic
particles increased the mechanical features of fibrin–agarose hydrogels. Moreover, chondrocytes
seeded in magnetic substrate expressed type II collagen. Magnetic hydrogels demonstrated a high
ability for hyaline cartilage-like tissue engineering [82].
Osteochondral flaws or cartilaginous damage can be treated using allogeneic cartilage
transplantation. Immune rejection is a challenging issue with grafting, though. Yang et al. used basic
fibroblast growth factor (BFGF) and agarose to regenerate the cartilage with minimum immunological
stimulation. Treated with BFGF, agarose and allogeneic cartilage resembled the autologous one.
The monocytes level in allografts was at its maximum level in the spleen and blood; the CD4+ T cells
number in the allogeneic group was greater than others. Allogeneic cartilage transplantation stimulates
acute immune rejection, which deals with the authenticity of the implant. The combination of BFGF
and agarose simplifies the aim of immune privilege and enhances the allograft tissues’ performance
(Figure 5) [83].Polymers 2020, 12, x FOR PEER REVIEW 2 of 16 
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Figure 5. cartilage injury after transplantation of different groups: (i) nontransplant control,
(ii) autologous articular cartilage (AU), (iii) allogeneic (same species, different rat) articular cartilage
(AL), (iv) allogeneic articular cartilage replacing a rose gel ( LA), (v) allogeneic ticular cartilage
replacing agarose gel with bFGF (ALAB), (vi) agarose gel (AG), and (vii) agarose gel with bFGF
(AGB). The cartilage restoration evaluation was drastically greater in the AU group than that in the AL
group, as was the ALAB group compared with the ALA group. Assessment of histological data after
transplantation. (A,B) Nontransplant control: amorphous reparative tissue filling the subchondral
region. AU: intensive staining covering the defect. AL: the intensity of staining in the regenerated
region was less than that of AU and ALAB. ALA: partly positive cartilage organization in the area.
ALAB: amounts of cartilage-like tissue restored in the full-thickness defect. AG and AGB showed the
agarose gel occupied the space and hindered the reconstructive process. (C) Histological findings in
knee cartilage in the transplantation site at postoperative week (POW) 3 and POW 6 (hematoxylin and
eosin). At POWs 3 and 6, the ALAB and AU groups showed no obvious evidence of rejection. In the
other two groups, chondrocytes with small, condensed nuclei were visible at each time point. Scale bar
is 50 µm for all images (Reprinted with permission form [83]).
5. Future Perspective and Concluding Remarks
Agarose is a wonderful biopolymer extracted from agar possessing extraordinary properties
such as excellent porous structure with interconnected pores to ease the nutrient, oxygen permeation,
and waste exchanges, the desired biodegradability and biocompatibility, a high ability to mimic
human tissue, perfect cell/matrix interaction, and great hydrophilicity and elasticity. Such promising
characteristics allow the migration/proliferation of cells, and a wide range of Young’s modulus
associated with ionic conductivity makes agarose a supreme applicant for the regeneration of many
human organs. The biggest advantage of agarose hydrogels is the encapsulation of chondrocytes and
cartilage cells at a cellular level which enables 3D cultures missing the loss of phenotype or morphology.
Cartilage tissue due to the absence of ample blood vessels and a low amount of stem cells requires a
suitable environment like hydrogels for filling the defected part when it gets damaged and makes a
human-tissue-like environment to help the regeneration process. Agarose and its composites presented
a conspicuous role in the regeneration of cartilage tissue. Distinctive characteristics of agarose-based
hydrogels such as excellent mechanical properties which can mimic the real hard/soft tissue with high
agreement, non-immunological, great biocompatibility, nontoxicity, and high cell/matrix interaction
have emphasized their application in cartilage repair research. The concerns and studies to fabricate
the best compatible agarose-based hydrogels for engineered tissue cartilage applications and the
development of complexes and interlinked types of agarose hydrogels have acquired more currency
amongst scientists. However, these hydrogels still need more advanced assessments in clinics and
real-world applications. Consequently, an additional organized attempt is crucial to filling the current
gap in cartilage repair that involves details of the main elements of agarose-based hydrogels. Moreover,
thanks to novel techniques such as bioprinting, the novel and precise 3D-printed scaffold can be
fabricated for cartilage regeneration.
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